Executive Leadership Team

Glooko Leadership Team

Our executive team features a diverse group of experienced healthcare and technology professionals who help guide Glooko to drive superior innovation and commercial results while transforming diabetes care.

Mike Alvarez

Chief Executive Officer

Rich Glenn

President of Connected Care

Mark Clements, M.D., Ph.D.

Chief Medical and Strategy Officer

Mark Beucler

Chief Financial Officer

Prakash Menon

Chief Technology Officer

Laura Tomaino

Chief People Officer

David Conn

Executive Vice President, Global Alliances

Mary Beth McDonald

Vice President, Regulatory and Quality Management

Clay Davidson

General Counsel

Board of Directors

Our board of directors is composed of industry executives and founders who support, advice, and enable Glooko to be the leader in diabetes management.

Charles Boorady

Founder & Managing Partner, Health Catalyst Capital

Simon Chong

Co-Founder & Managing Partner, Georgian Partners

Wende Hutton

General Partner, Canaan Partners

Tracy Bahl

OneOncology, CVS, General Atlantic, Emdeon, UHG

Enrique Conterno

Former Eli Lilly & Company Senior Executive

Yogen Dalal

Founder, Glooko Board Observer

Mark Laret

Former UCSF Health CEO and National Healthcare Leader

Clinical Advisory Board

Composed of leading diabetes experts, our Clinical Advisory Board offers us essential insights, advice, and ideas stemming from their hands-on use of Glooko and own clinical practices. This collaboration enables us to innovate our diabetes management platform.